Sign in
WithdrawnPhase 4

Statin Therapy In Patients With Vasospastic Angina

Key facts

Who runs it
Seung-Jung Park
Where
South Korea1 site in 1 countryChoose a country to see its sites
Trial code
Status
Withdrawn
Phase
Phase 4
Started
Jul 2017
Ended
Dec 2023
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Atorvastatin
  • Placebo
Record updated
15 June 2017
Why it stopped
Funding issue

Who can take part

Age
19 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Age 19 and more
  • Vasospastic angina
  • LDL less than 160mg/dl
  • Written consent

Who cannot take part

  • Dyslipidemia required statin therapy
  • Coronary artery stenosis more than 50% or ischemic coronary disease
  • History of percutaneous coronary intervention
  • Cerebrovascular diseases or peripheral
  • Heart failure, arrhythmogenic right ventricular dysplasia, hypertrophic cardiomyopathy, akinesia or aneurysm on left ventricular wall, anomaly of coronary artery
  • Arrhythmia
  • Primary cardiac electrical diseases
  • Cardiac pacemaker or implantable defibrillator
  • NYHA III and IV
  • Pregnancy or breast feeding
  • Life expectancy less than 2 years

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this study is to evaluate whether statin is effective in the treatment of vasospastic angina.

The 2 groups in the trial

  • AtorvastatinTreatment being tested

    20mg QD

  • PlaceboPlacebo, for comparison

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of Statin Therapy In Patients With Vasospastic Angina
Record updated
15 June 2017